| CTRI Number |
CTRI/2025/06/089292 [Registered on: 23/06/2025] Trial Registered Prospectively |
| Last Modified On: |
27/11/2025 |
| Post Graduate Thesis |
No |
| Type of Trial |
Interventional |
|
Type of Study
|
Other (Specify) [Oral care product] |
| Study Design |
Single Arm Study |
|
Public Title of Study
|
Clinical Study on efficacy of Activated Charcoal Pro plus toothpaste. |
|
Scientific Title of Study
|
Evaluation of the efficacy of Activated Charcoal Pro plus toothpaste in improving teeth whitening and overall oral hygiene improvement. |
| Trial Acronym |
NIL |
|
Secondary IDs if Any
|
| Secondary ID |
Identifier |
| MHC/CT/25-26/004 Version: 1.00; dated, 15 April 2025 |
Protocol Number |
|
|
Details of Principal Investigator or overall Trial Coordinator (multi-center study)
|
| Name |
Dr Bhagyashri Gunjkar |
| Designation |
Principal Investigator |
| Affiliation |
Gunjkar Multispeciality Hospital |
| Address |
Plot No 315, Sector No 18, Spine Road, Chikhali
Pune MAHARASHTRA 411062 India |
| Phone |
9823776981 |
| Fax |
- |
| Email |
drbhagyashri.gunjkarresearch@gmail.com |
|
Details of Contact Person Scientific Query
|
| Name |
Dr Rhythm Batra |
| Designation |
Manager- Product Awareness & Research |
| Affiliation |
Chipper Consumer Pvt. Ltd |
| Address |
Plot No. 250, Lynx House, 3rd Floor, Udyog Vihar, Phase IV, Sector 18,NCR.
Gurgaon HARYANA 122015 India |
| Phone |
9711887082 |
| Fax |
- |
| Email |
rhythm@perforacare.com |
|
Details of Contact Person Public Query
|
| Name |
Mr Ashish Goel |
| Designation |
Lead- NPD & SCM |
| Affiliation |
Chipper Consumer Pvt. Ltd |
| Address |
Plot No. 250, Lynx House, 3rd Floor, Udyog Vihar, Phase IV, Sector 18,NCR.
Gurgaon HARYANA 122015 India |
| Phone |
9953777707 |
| Fax |
- |
| Email |
ashish@perforacare.com |
|
|
Source of Monetary or Material Support
|
| Chipper Consumer Pvt. Ltd. Plot No. 250, Lynx House, 3rd Floor, Udyog Vihar, Phase IV, Sector 18,Gurugram, Haryana-122015, NCR, India. |
|
Primary Sponsor
Modification(s)
|
| Name |
Chipper Consumer Pvt Ltd Perfora |
| Address |
Plot No. 250, Lynx House, 3rd Floor, Udyog Vihar, Phase IV, Sector 18,Gurugram, Haryana-122015, NCR, India. |
| Type of Sponsor |
Other [Cosmeceutical Industry] |
|
|
Details of Secondary Sponsor
|
|
|
Countries of Recruitment
|
India |
|
Sites of Study
|
| No of Sites = 1 |
| Name of Principal
Investigator |
Name of Site |
Site Address |
Phone/Fax/Email |
| Dr Bhagyashri Gunjkar |
Gunjkar Multispeciality Hospital |
Plot No 315, Sector No 18,
Spine Road, Chikhali, Pune Pune MAHARASHTRA |
9823776981 - drbhagyashri.gunjkarresearch@gmail.com |
|
|
Details of Ethics Committee
|
| No of Ethics Committees= 1 |
| Name of Committee |
Approval Status |
| Institutional Ethics Committee Sangvi Multispecialty Hospital |
Approved |
|
|
Regulatory Clearance Status from DCGI
|
|
|
Health Condition / Problems Studied
|
| Health Type |
Condition |
| Healthy Human Volunteers |
Oral Health and Teeth Whitening |
|
|
Intervention / Comparator Agent
|
| Type |
Name |
Details |
| Intervention |
Activated Charcoal Pro+ toothpaste |
All participants will be advised to use a pea-sized amount of Activated Charcoal Pro+ toothpaste, gently brushing their teeth twice a day, in the morning and at night after meals, and then rinsing with clean water for 8 weeks. |
| Comparator Agent |
NIL |
NIL |
|
|
Inclusion Criteria
|
| Age From |
25.00 Year(s) |
| Age To |
45.00 Year(s) |
| Gender |
Both |
| Details |
1.Healthy males and females aged 25 to 45 years (both included);
2.Individuals with generally healthy oral tissues, without inflammation, redness, or pain, as confirmed by a comprehensive dental examination. This includes no current or recent (within the last 6 months) periodontal treatment or significant oral diseases;
3.Participants with perceived teeth discoloration and need to improve teeth whiteness and overall oral hygiene;
4.Participants with mild and moderate plaque with plaque index 2-4;
5.Participants who have all incisors and canines in the upper and lower jaw;
6.Individuals in good general health without any systemic conditions or medications that could affect oral health or interfere with the study treatments;
Participants who provide written informed consent to participate in the study and comply with all study procedures and requirements. |
|
| ExclusionCriteria |
| Details |
1.Participants with A1, B1 and C1 shade on Vita Shade scale
2.Individuals with current alcohol or tobacco use
3.Known sensitivity or history of significant adverse effects to any of the investigational products
4.Significant unstable or uncontrolled medical condition which may interfere with a participant participation in the study
5.Participated in tooth stain removal trials in the least 3 months;
6.Individuals who are unable to adhere to the study protocol or have conditions that may interfere with compliance, including cognitive impairments or language barriers;
7.Participants using antibiotics or other medications that could affect oral health or interfere with the study results;
8.Participants involved in concurrent studies with similar assessments or interventions;
9.Participants experiencing severe dry mouth (xerostomia);
10.Participants with chronic bad breath (halitosis) due to treatment or any medical condition;
11.Participants with any known hypersensitivity of charcoal containing oral care products. |
|
|
Method of Generating Random Sequence
|
Computer generated randomization |
|
Method of Concealment
|
Case Record Numbers |
|
Blinding/Masking
|
Open Label |
|
Primary Outcome
|
| Outcome |
TimePoints |
1.Changes in teeth whitening assessed by VITA Shade Scale at screening, week 4, and week 8.
2.Changes in Investigational Product on Plaque Index (PI) at screening, week 4, and week 8. |
Screening, week 4, and week 8. |
|
|
Secondary Outcome
|
| Outcome |
TimePoints |
1.Changes in Macpherson’s Modified Stain Index at baseline, week 4 and week 8.
2.Changes in Organoleptic Scoring Scale (OSS) at baseline, week 4, and week 8.
3.Compliance and tolerability will be assessed at week 4 and week 8. |
Screening, week 4, and week 8. |
|
|
Target Sample Size
|
Total Sample Size="30" Sample Size from India="30"
Final Enrollment numbers achieved (Total)= "32"
Final Enrollment numbers achieved (India)="32" |
|
Phase of Trial
|
N/A |
|
Date of First Enrollment (India)
|
01/07/2025 |
| Date of Study Completion (India) |
24/09/2025 |
| Date of First Enrollment (Global) |
Date Missing |
| Date of Study Completion (Global) |
Date Missing |
|
Estimated Duration of Trial
|
Years="0" Months="5" Days="0" |
|
Recruitment Status of Trial (Global)
|
Not Applicable |
| Recruitment Status of Trial (India) |
Completed |
Publication Details
Modification(s)
|
Not yet published |
|
Individual Participant Data (IPD) Sharing Statement
|
Will individual participant data (IPD) be shared publicly (including data dictionaries)?
Response - NO
|
Brief Summary
Modification(s)
|
This clinical study is designed to rigorously evaluate the efficacy of Activated Charcoal Pro+ toothpaste in improving tooth color and reducing plaque accumulation over an 8-week period. Despite the growing popularity of charcoal-based dentifrices, there is limited clinical evidence supporting their benefits beyond cosmetic effects. This study aims to address this gap by using validated indices such as the VITA Shade Scale for tooth color assessment, along with the Plaque Index and Macpherson’s Modified Stain Index, to quantify changes in oral hygiene status. The Organoleptic Scoring Scale will further evaluate breath quality, providing a holistic assessment of oral health. Continuous safety monitoring, including adverse event reporting and assessments of compliance and tolerability, will ensure a comprehensive safety profile. The findings will contribute valuable evidence regarding the clinical utility, safety, and potential role of activated charcoal-based toothpaste in daily oral hygiene practices, supporting evidence-based recommendations for both consumers and dental professionals. |